Navigation Links
Stopping Statins After Stroke Doubles Death Risk

Almost 40% of patients stopped taking drugs in Italian study

THURSDAY, Aug. 30 (HealthDay News) -- Stroke survivors who stopped taking cholesterol-lowering statins doubled their risk of dying in the next year compared to those who stayed on the medications, an Italian study finds.

A number of other studies have shown the benefits of using statins after a stroke, the study authors noted.

For instance, the Italian study comes on the heels of a Spanish study that found discontinuation of statin therapy by stroke patients is associated with an increased risk of death or dependency after 90 days.

The Spanish study of 89 people who had been taking statins before suffering a stroke found that 27 of the 46 patients who had an interruption of statin therapy were dead or dependent after three months, compared to only 16 of 43 who did not stop taking statins.

The American Heart Association currently recommends statin therapy after a stroke, said Dr. Larry Goldstein, director of the stroke center at Duke University. That recommendation was made before completion of a U.S. study "that showed for the first time that starting patients with no known cardiac disease after a stroke produced a significant reduction in the rate of recurrent stroke and in fatal stroke," Goldstein said.

The Italian study, by physicians at the San Filippo Neri Hospital in Rome and published in the Aug. 31 issue of Stroke, was "very well done," Goldstein said. It followed 631 stroke survivors whose average age was 70 and who had no other major illness, including heart disease. All were discharged from the hospital with orders to take a drug regimen that included statins.

But by the end of the four-and-a-half-year study, 38.9 percent of the patients had stopped taking statins, most of them quickly. The average time to discontinuation was 48.6 days.

A statistical analysis showed that discontinuing statin therapy was an independent risk factor for death from all causes. Eighty percent of the deaths recorded in the study were from cardiovascular disease.

About a quarter of the patients who stopped taking statins cited mild side effects, the most common of which was indigestion. No specific reason for discontinuing the drug therapy was given by the other patients or their doctors.

Current practice at Duke is to prescribe statins in many cases after a stroke, Goldstein said. "A patient who has coronary heart disease or diabetes should be on a statin," he said. "If there is no known coronary heart disease, we prescribe a statin for someone whose LDL cholesterol is between 100 and 190."

The Italian study also showed an increased risk of death in stroke survivors who stopped taking an anti-clotting drug such as Plavix, Goldstein noted. Their risk of death was 80 percent higher than in patients who took the drug as prescribed.

"Discontinuing either statins or antiplatelet drugs was associated with an increase in all-cause mortality," Goldstein said.

"Effective clinical strategies are needed to bring out a significant increase in patients who maintain their drug therapies," study author Dr. Furio Colivicchi said in a statement.

Many stroke survivors are eager to stop taking the medications, said Dr. Matthew Fink, chief of the division of stroke and critical care neurology at Weill Cornell Medical College in New York City. They generally are older people who are vulnerable to arthritis, he said.

"They have a tendency to have aches and pains, and they blame them on the statin," he said. "It's not due to the drug, but it's hard to convince them."

The two new reports both show that "most people who have had ischemic strokes should be treated with statins as part of their overall treatment," Fink said. Most strokes are ischemic, caused by blockage of a brain artery by a clot.

"The Spanish study looked at the acute effects in the hospital," Fink said. "The Italian study looked at the effect on outpatients. Both studies show the importance of continuing on these medications. When you start them, stay on them," he said.

More information

Complete information on stroke treatment and recovery is provided by the National Library of Medicine.

SOURCES: Larry Goldstein, M.D., director, stroke center, Duke University, Durham, N.C.; Matthew Fink, M.D., chief of the division of stroke and critical care neurology, Weill Cornell Medical College, New York City; Aug. 31, 2007, Stroke

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Therapy for stopping the spread of cancer cells
2. Stopping Prostate Cancer from Spreading
3. Stopping The Progression Of Parkinsons Disease
4. Stopping The Growth Of Viruses
5. Stopping The Growth Of Viruses
6. The Consequences Of Stopping Physical Activity
7. Study Finds Parkinson’s Cell Death Blocked by Stopping Inflammatory Facto
8. The Odds Of Stopping Smoking
9. Statins reduce heart attacks
10. The Effects of Statins Questioned
11. Statins reduce risks for angioplasty patients
Post Your Comments:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: